IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Depreciation & Amortization (CF) (2018 - 2026)

Updated

IRulya Therapeutics (IRLA) posted Depreciation & Amortization (CF) of $41,000 for Q2 2026, up 17.1% from $35,000 a year earlier and up 13.9% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at IRulya Therapeutics was $152,000, down 10.1% year-over-year; for FY2025, it was $142,000, down 23.7% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
  • In prior years, IRulya Therapeutics' Depreciation & Amortization (CF) was $186,000 in FY2024 (-42.2%), $322,000 in FY2023 (+57.8%), $204,000 in FY2022 (-40.7%) and $344,000 in FY2021 (+3.6%).
  • The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) since Q3 2024.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last three quarters, with an average decline of 2.8% over the last seven quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 623.8%; the weakest was Q2 2023, with a decline of 98.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $36,000 (Q1 2026), $39,000 (Q4 2025) and $36,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.12 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 192.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 132.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.58 Bn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - 41,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41,000.00
Mar 31, 2026 36,000.00
Dec 31, 2025 39,000.00
Sep 30, 2025 36,000.00
Jun 30, 2025 35,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 16,000.00
Sep 30, 2024 86,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 304,000.00
Jun 30, 2023 1,000.00
Mar 31, 2023 17,000.00
Dec 31, 2022 42,000.00
Sep 30, 2022 40,000.00
Jun 30, 2022 84,000.00
Mar 31, 2022 38,000.00
Dec 31, 2021 84,000.00
Sep 30, 2021 87,000.00
Jun 30, 2021 87,000.00
API Access

IRulya Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IRLA&period=max&api_key=YOUR_API_KEY